Benzinga | Nov 4, 2021 07:31AM EDT

Aeglea BioTherapeutics Q3 EPS $(0.31) Down From $(0.29) YoY, Sales $1.40M

Aeglea BioTherapeutics (NASDAQ:AGLE) reported quarterly losses of $(0.31) per share. This is a 6.9 percent decrease over losses of $(0.29) per share from the same period last year. The company reported $1.40 million in sales this quarter.